Developer docs
API playgroundTry for free, no card

Search company profiles

Smartway Pharmaceuticals

Full company profile

uuid000c8ur

Namestring
Smartway Pharmaceuticals
Legal namestring
Smartway Pharmaceuticals Limited
Company typeenum
Private
Founded yearint
1992
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical wholesale, pharmaceutical distribution, unlicensed medicines supply, early access programs, comparator drug supply
Industry2 codes
PRIMARYHLAIAJAB
Specialty Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAFALAE
Compounding Pharmacies (Sterile/Non-Sterile)
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
NAICS code6 codes
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmacies and Drug Retailers456110
  • Pharmaceutical and Medicine Manufacturing32541
  • Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers42345
SIC code4 codes
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Pharmaceutical Preparations2834
  • Retail-Drug Stores And Proprietary Stores5912
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Pharmaceutical Distribution and Wholesale
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1Pharmaceutical Distribution & Wholesale
TypeTransaction Fee
Description

Core revenue from global distribution and wholesale of branded and generic pharmaceuticals, unlicensed medicines, specials, and imported medicines. Revenue generated through procurement and supply of pharmaceuticals to healthcare providers, hospitals, pharmacies, and wholesalers across 98 countries.

smartwaypharma.co.uk
2Early Access Programs (EAP)
TypeProfessional Services
Description

Design, implementation and global management of Expanded Access, Early Access, Compassionate Use and Named Patient Programs for pharma and biotech companies. Services include regulatory strategy, program design, global supply chain, and real world data collection.

smartwaypharma.co.uk
3Comparator/RLD Supply
TypeTransaction Fee
Description

Supply of comparators, RLDs (Reference Listed Drugs), samples and biosimilar samples to manufacturers, CROs and CDMOs for clinical trials. Global supply chain built over 30 years with direct manufacturer relationships.

smartwaypharma.co.uk
4Sexual Health Supply
TypeTransaction Fee
Description

Specialist distribution of contraceptive medicines and disposable instruments. Includes over 500 pharmaceutical and medical device products, over-labelling services, and bespoke kitting services.

smartwaypharma.co.uk
5Market Access & Product Commercialisation
TypeLicensing Royalties
Description

In-licensing and product selection, regulatory strategy and execution, licensed supply and commercial launch, lifecycle and portfolio management. Structured inward licensing arrangements supporting regulatory approval and MAH-based commercialisation.

smartwaypharma.co.uk
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels7 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 2 records shown
1SmartMed
Description

Digital portal for unlicensed medicines providing quick access to product documentation, batch-specific data, support materials, market shortage updates, and API disruption information for hospital pharmacists, technicians, and clinicians.

smartwaypharma.co.uk
+1 more record
Core offering1 text field

Smartway Pharmaceuticals is a global pharmaceutical wholesaler and distributor that sources and supplies branded, generic, unlicensed, shortage, specials, imported and controlled medicines to healthcare professionals, hospitals, pharmacies, pharma and biotech companies, wholesalers and aid organisations across 98 countries. The company also designs and manages Early Access Programs (Expanded Access, Compassionate Use and Named Patient Programs), supplies comparator drugs and reference listed drugs for clinical trials, and operates an online pharmacy for private prescriptions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 5 million packs shipped globally in last 5 years
+4 more records
Product overview1 text field

Smartway Pharmaceuticals operates as a global pharmaceutical wholesaler and distributor offering a comprehensive portfolio of products and services. The company provides both digital platforms and service offerings. Key digital products include SmartMed (portal for unlicensed medicines information), SmartRx (e-prescribing platform), and SMARThub (EAP management system). Service offerings span Early Access Programs, Hospital & Pharmacy Supply, Aid & Development, Comparator/RLD Supply, Sexual Health Supply (Smartway Sexual Health), Specialist Distribution, International Supply & Unlicensed Imports, and Market Access & Product Commercialisation. The company leverages distribution hubs in the EU, UK, Dubai, India, and USA to serve healthcare professionals, pharmaceutical companies, wholesalers/distributors, aid organisations, and patients across 98 countries.

Product and service2 records
1Early Access Programs (EAP)
CategoryManaged Access Program Service
Description

Global programs that empower access to innovative therapies before commercial launch. Smartway designs, implements, and manages Expanded Access, Early Access, Compassionate Use and Named Patient Programs across 98 countries in partnership with pharma and biotech companies. Services include regulatory strategy, program design, global supply chain, and real-world data collection.

2Hospital & Pharmacy Supply
Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-08-10
Description

Strategic partnership for global Early Access Program for KYZATREX™ (testosterone undecanoate) addressing global issue of hypogonadism. Smartway designs and manages comprehensive EAP to enable access to therapies before commercially launched.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-05-03
Description

Partnership for international Early Access Programs for Ambrose products treating rare diseases. Smartway serves as exclusive supplier of end-to-end EAP services including regulatory design and submission, and global compliant distribution of therapeutics under international EAPs. Ambrose Healthcare is a specialist pharmaceutical company addressing unmet medical needs in rare disease.

3Thyroid UK
Strategic tierSupportingTypeOthers
Description

Charity partnership to help patients access thyroid medications. Smartway works with Thyroid UK to ensure patients can access their needed medicine through pharmacies and wholesalers.

smartwaypharma.co.uk
4NHS
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

NHS approved supplier for over 25 years. Supplies unlicensed imports and specials to all UK NHS Trusts. Partnered with NHS on medicine waste reduction through breakdown and repackaging of medicines.

smartwaypharma.co.uk
Strategic tierSupportingTypeChannel Partner/ Reseller/ Distributor
Description

Working with UK Department of Health on medicine shortage challenges including importing unlicensed medicines to ensure patient access.

6UK Non-profit Sexual Health Organizations
Strategic tierSupportingTypeChannel Partner/ Reseller/ Distributor
Description

Partnership with one of the largest non-profit organisations in the UK for providing contraceptive methods. Smartway provides comprehensive range of contraceptive medicines to support healthcare providers.

smartwaypharma.co.uk
Strategic tierSupportingTypeOthers
Description

Adopted relevant UN Sustainable Development Goals. Initial focus on Goal 3 (Good Health and Wellbeing) through access to medicines globally. Committed to carbon neutral programs including charitable tree planting projects for carbon capture.

Recent move12 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

UK's largest pharmaceutical wholesaler and distributor, supplying independent pharmacies, hospitals, and clinics across the UK and Europe. Directly comparable as a UK-headquartered pharma wholesaler competing for NHS framework agreements and hospital pharmacy contracts, though at significantly larger scale than Smartway.

TypeDirect peer
Description

Global pharmaceutical services company specialising in Managed Access (Early Access/Named Patient) Programs, unlicensed medicine supply, and clinical trial supply. The closest direct competitor to Smartway's EAP, Comparator/RLD, and unlicensed medicines service lines, with overlapping customer base of pharma/biotech manufacturers.

3McKesson Europe (Lloyds Pharmacy Healthcare)
TypeBroad incumbent
Description

One of the world's largest pharmaceutical wholesalers and distributors, with deep UK/European footprint through Lloyds Pharmacy and AAH Pharmaceuticals. Comparable as a full-line pharma wholesaler serving hospitals, pharmacies, and manufacturers, though operating at much greater scale across a broader portfolio.

TypeBroad incumbent
Description

Leading European pharmaceutical distribution company operating across 27+ countries with comprehensive wholesale, retail pharmacy, and pharma services businesses. Comparable as a continental pharma wholesaler with hospital pharmacy services, though with materially larger geographic and SKU coverage than Smartway.

TypeDirect peer
Description

UK-based specialist pharmaceutical wholesaler and distributor focused on unlicensed medicines, clinical trial supply, and named-patient programs. Closely comparable to Smartway in scale and service mix — both serve NHS Trusts and pharma manufacturers with shortage, unlicensed, and comparator supply from UK bases.

TypeBroad incumbent
Description

Specialist pharmaceutical services business within Walgreens Boots Alliance focused on clinical trial supply, homecare, and patient access services. Comparable to Smartway's Comparator/RLD supply and EAP/Market Access lines, though operating as part of a much larger parent group.

TypeDirect peer
Description

UK specialist pharmaceutical distributor providing wholesale, unlicensed medicines, and pharmacy services to NHS Trusts and the broader healthcare market. Comparable to Smartway's hospital/pharmacy supply business with similar UK regulatory positioning and NHS framework participation.

8Lexon UK
TypeDirect peer
Description

UK pharmaceutical wholesaler and parallel distributor specialising in unlicensed and imported medicines, with NHS framework participation. Closely comparable to Smartway's International Supply & Unlicensed Imports service line and shortage-response capability.

TypeBroad incumbent
Description

One of the largest global pharmaceutical distributors and services providers, with specialty distribution and clinical trial supply capabilities (through World Courier and PharmaLex-adjacent offerings). Comparable to Smartway in pharma distribution and global reach, but operating at vastly greater scale with deep manufacturer partnerships.

10IDIS Group (now part of Norgine)
TypeDirect peer
Description

Specialist pharmaceutical company historically focused on named-patient/managed access programs and unlicensed medicine supply in Europe. Comparable to Smartway's EAP and unlicensed medicines operations with similar regulatory-driven service model and pharma/biotech customer base.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Smartway Pharmaceuticals

Pharmaceutical Distribution and Wholesalesmartwaypharma.co.uk

Smartway Pharmaceuticals firmographics

Firmographics
Name
Smartway Pharmaceuticals
Legal name
Smartway Pharmaceuticals Limited
Website
https://smartwaypharma.co.uk
Company type
Private
Founded year
1992
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

Smartway Pharmaceuticals industry classification

Industry
Product category
Pharmaceutical Distribution and Wholesale
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (42421), Pharmaceutical Preparation Manufacturing (325412), Pharmacies and Drug Retailers (456110), Pharmaceutical and Medicine Manufacturing (32541), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834), Retail-Drug Stores And Proprietary Stores (5912), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro industry
PRIMARYHLAIAJAB
Specialty Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAFALAE
Compounding Pharmacies (Sterile/Non-Sterile)
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services

Keywords

  • Pharmaceutical wholesale
  • Pharmaceutical distribution
  • Unlicensed medicines supply
  • Early access programs
  • Comparator drug supply

Where Smartway Pharmaceuticals is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices7 records

Markets served

Smartway Pharmaceuticals business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Pharmaceutical Distribution & Wholesale: Core revenue from global distribution and wholesale of branded and generic pharmaceuticals, unlicensed medicines, specials, and imported medicines. Revenue generated through procurement and supply of pharmaceuticals to healthcare providers, hospitals, pharmacies, and wholesalers across 98 countries.
  2. Early Access Programs (EAP): Design, implementation and global management of Expanded Access, Early Access, Compassionate Use and Named Patient Programs for pharma and biotech companies. Services include regulatory strategy, program design, global supply chain, and real world data collection.
  3. Comparator/RLD Supply: Supply of comparators, RLDs (Reference Listed Drugs), samples and biosimilar samples to manufacturers, CROs and CDMOs for clinical trials. Global supply chain built over 30 years with direct manufacturer relationships.
  4. Sexual Health Supply: Specialist distribution of contraceptive medicines and disposable instruments. Includes over 500 pharmaceutical and medical device products, over-labelling services, and bespoke kitting services.
  5. Market Access & Product Commercialisation: In-licensing and product selection, regulatory strategy and execution, licensed supply and commercial launch, lifecycle and portfolio management. Structured inward licensing arrangements supporting regulatory approval and MAH-based commercialisation.

Go-to-market motion3 records

Distribution channels7 records

Marketing channels7 records

Smartway Pharmaceuticals product offering

Product offering

Core offering

Smartway Pharmaceuticals is a global pharmaceutical wholesaler and distributor that sources and supplies branded, generic, unlicensed, shortage, specials, imported and controlled medicines to healthcare professionals, hospitals, pharmacies, pharma and biotech companies, wholesalers and aid organisations across 98 countries. The company also designs and manages Early Access Programs (Expanded Access, Compassionate Use and Named Patient Programs), supplies comparator drugs and reference listed drugs for clinical trials, and operates an online pharmacy for private prescriptions.

Product overview

Smartway Pharmaceuticals operates as a global pharmaceutical wholesaler and distributor offering a comprehensive portfolio of products and services. The company provides both digital platforms and service offerings. Key digital products include SmartMed (portal for unlicensed medicines information), SmartRx (e-prescribing platform), and SMARThub (EAP management system). Service offerings span Early Access Programs, Hospital & Pharmacy Supply, Aid & Development, Comparator/RLD Supply, Sexual Health Supply (Smartway Sexual Health), Specialist Distribution, International Supply & Unlicensed Imports, and Market Access & Product Commercialisation. The company leverages distribution hubs in the EU, UK, Dubai, India, and USA to serve healthcare professionals, pharmaceutical companies, wholesalers/distributors, aid organisations, and patients across 98 countries.

Differentiator

Problem solved

Functional benefit

Brands

  • SmartMed: Digital portal for unlicensed medicines providing quick access to product documentation, batch-specific data, support materials, market shortage updates, and API disruption information for hospital pharmacists, technicians, and clinicians.
  • SmartRx

Products and services

  • Early Access Programs (EAP) Global programs that empower access to innovative therapies before commercial launch. Smartway designs, implements, and manages Expanded Access, Early Access, Compassionate Use and Named Patient Programs across 98 countries in partnership with pharma and biotech companies. Services include regulatory strategy, program design, global supply chain, and real-world data collection.
  • Hospital & Pharmacy Supply

Quantifiable outcome

  • 5 million packs shipped globally in last 5 years
  • +4 more outcomes

Companies that use Smartway Pharmaceuticals

Customer profile

Named customers7 records

Segments5 records

Ideal customer profiles5 records

Smartway Pharmaceuticals technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Smartway Pharmaceuticals partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and supporting.

  • Marius PharmaceuticalscoreStrategic or Co-development Partner · 10 August 2023Strategic partnership for global Early Access Program for KYZATREX™ (testosterone undecanoate) addressing global issue of hypogonadism. Smartway designs and manages comprehensive EAP to enable access to therapies before commercially launched.
  • Ambrose HealthcarecoreStrategic or Co-development Partner · 3 May 2023Partnership for international Early Access Programs for Ambrose products treating rare diseases. Smartway serves as exclusive supplier of end-to-end EAP services including regulatory design and submission, and global compliant distribution of therapeutics under international EAPs. Ambrose Healthcare is a specialist pharmaceutical company addressing unmet medical needs in rare disease.
  • Thyroid UKsupportingOthersCharity partnership to help patients access thyroid medications. Smartway works with Thyroid UK to ensure patients can access their needed medicine through pharmacies and wholesalers.
  • NHScoreChannel Partner/ Reseller/ DistributorNHS approved supplier for over 25 years. Supplies unlicensed imports and specials to all UK NHS Trusts. Partnered with NHS on medicine waste reduction through breakdown and repackaging of medicines.
  • UK Department of HealthsupportingChannel Partner/ Reseller/ DistributorWorking with UK Department of Health on medicine shortage challenges including importing unlicensed medicines to ensure patient access.
  • UK Non-profit Sexual Health OrganizationssupportingChannel Partner/ Reseller/ DistributorPartnership with one of the largest non-profit organisations in the UK for providing contraceptive methods. Smartway provides comprehensive range of contraceptive medicines to support healthcare providers.
  • UN Sustainable Development GoalssupportingOthersAdopted relevant UN Sustainable Development Goals. Initial focus on Goal 3 (Good Health and Wellbeing) through access to medicines globally. Committed to carbon neutral programs including charitable tree planting projects for carbon capture.

Scale indicators11 records

Recent moves12 records

Expansion highlights5 records

Smartway Pharmaceuticals competitors and assessment

Company assessment

Direct peers

  • Alliance Healthcare: UK's largest pharmaceutical wholesaler and distributor, supplying independent pharmacies, hospitals, and clinics across the UK and Europe. Directly comparable as a UK-headquartered pharma wholesaler competing for NHS framework agreements and hospital pharmacy contracts, though at significantly larger scale than Smartway.
  • Clinigen Group: Global pharmaceutical services company specialising in Managed Access (Early Access/Named Patient) Programs, unlicensed medicine supply, and clinical trial supply. The closest direct competitor to Smartway's EAP, Comparator/RLD, and unlicensed medicines service lines, with overlapping customer base of pharma/biotech manufacturers.
  • Durbin PLC: UK-based specialist pharmaceutical wholesaler and distributor focused on unlicensed medicines, clinical trial supply, and named-patient programs. Closely comparable to Smartway in scale and service mix — both serve NHS Trusts and pharma manufacturers with shortage, unlicensed, and comparator supply from UK bases.
  • Mawdsleys: UK specialist pharmaceutical distributor providing wholesale, unlicensed medicines, and pharmacy services to NHS Trusts and the broader healthcare market. Comparable to Smartway's hospital/pharmacy supply business with similar UK regulatory positioning and NHS framework participation.
  • Lexon UK: UK pharmaceutical wholesaler and parallel distributor specialising in unlicensed and imported medicines, with NHS framework participation. Closely comparable to Smartway's International Supply & Unlicensed Imports service line and shortage-response capability.
  • IDIS Group (now part of Norgine): Specialist pharmaceutical company historically focused on named-patient/managed access programs and unlicensed medicine supply in Europe. Comparable to Smartway's EAP and unlicensed medicines operations with similar regulatory-driven service model and pharma/biotech customer base.

Broad incumbents

  • McKesson Europe (Lloyds Pharmacy Healthcare): One of the world's largest pharmaceutical wholesalers and distributors, with deep UK/European footprint through Lloyds Pharmacy and AAH Pharmaceuticals. Comparable as a full-line pharma wholesaler serving hospitals, pharmacies, and manufacturers, though operating at much greater scale across a broader portfolio.
  • Phoenix Group: Leading European pharmaceutical distribution company operating across 27+ countries with comprehensive wholesale, retail pharmacy, and pharma services businesses. Comparable as a continental pharma wholesaler with hospital pharmacy services, though with materially larger geographic and SKU coverage than Smartway.
  • Alcura (Walgreens Boots Alliance): Specialist pharmaceutical services business within Walgreens Boots Alliance focused on clinical trial supply, homecare, and patient access services. Comparable to Smartway's Comparator/RLD supply and EAP/Market Access lines, though operating as part of a much larger parent group.
  • Cencora (formerly AmerisourceBergen): One of the largest global pharmaceutical distributors and services providers, with specialty distribution and clinical trial supply capabilities (through World Courier and PharmaLex-adjacent offerings). Comparable to Smartway in pharma distribution and global reach, but operating at vastly greater scale with deep manufacturer partnerships.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Smartway Pharmaceuticals social profiles

Digital presence

Smartway Pharmaceuticals compliance and trust

Trust signal

Compliance7 records

Smartway Pharmaceuticals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Smartway Pharmaceuticals leadership team

Management profile

Number of profiles

Profiles11 records

Smartway Pharmaceuticals subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Smartway Pharmaceuticals funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Smartway Pharmaceuticals M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Smartway Pharmaceuticals

What does Smartway Pharmaceuticals do?

Smartway Pharmaceuticals is a global pharmaceutical wholesaler and distributor that sources and supplies branded, generic, unlicensed, shortage, specials, imported and controlled medicines to healthcare professionals, hospitals, pharmacies, pharma and biotech companies, wholesalers and aid organisations across 98 countries. The company also designs and manages Early Access Programs (Expanded Access, Compassionate Use and Named Patient Programs), supplies comparator drugs and reference listed drugs for clinical trials, and operates an online pharmacy for private prescriptions.

Is Smartway Pharmaceuticals a public or private company?

Smartway Pharmaceuticals is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Smartway Pharmaceuticals founded?

Smartway Pharmaceuticals was founded in 1992. It employs 101 to 250 people.

Where is Smartway Pharmaceuticals based?

Smartway Pharmaceuticals is headquartered in London, United Kingdom, in the Europe region.

How does Smartway Pharmaceuticals make money?

Five revenue lines are on record. Pharmaceutical Distribution & Wholesale is the primary driver. The others are early Access Programs (EAP), comparator/RLD Supply, sexual Health Supply and market Access & Product Commercialisation.

Who are Smartway Pharmaceuticals's main competitors?

Direct peers on record are Alliance Healthcare, Clinigen Group, Durbin PLC, Mawdsleys, Lexon UK and IDIS Group (now part of Norgine). Broad incumbents are McKesson Europe (Lloyds Pharmacy Healthcare), Phoenix Group, Alcura (Walgreens Boots Alliance) and Cencora (formerly AmerisourceBergen).

Does Smartway Pharmaceuticals have an API?

No public API is recorded for Smartway Pharmaceuticals.

What industry is Smartway Pharmaceuticals in?

Smartway Pharmaceuticals's product category is Pharmaceutical Distribution and Wholesale. Its primary akta.pro industry code is HLAIAJAB, Specialty Pharmaceutical Distributors, with a secondary code of HLAFALAE, Compounding Pharmacies (Sterile/Non-Sterile). Its NAICS code is 424210 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireTilray erweitert den pharmazeutischen Zugang im Vereinigten Königreich durch eine strategische Vereinbarung mit Smartway PharmaceuticalsTilray's pharmaceutical division, CC Pharma, announced a strategic partnership with Smartway Pharmaceuticals in the UK to expand the availability of pharmaceutical products, enhance supply reliability, and increase market reach. This agreement leverages Smartway's distribution infrastructure and CC Pharma's GMP capacity, representing a key step in Tilray's European expansion strategy.Quiver QuantitativeTilray Pharma and Smartway Pharmaceuticals Forge Strategic Agreement to Enhance Pharmaceutical Distribution in the UKTilray Pharma's subsidiary CC Pharma and Smartway Pharmaceuticals entered into a strategic agreement to expand pharmaceutical distribution in the UK. The partnership aims to improve access, reliability, and reach of medicinal products in the UK market, valued at nearly £1 billion.GlobeNewswireTilray Expands UK Pharmaceutical Access Through Strategic Agreement with Smartway PharmaceuticalsTilray's CC Pharma and UK distributor Smartway Pharmaceuticals signed a strategic agreement to expand pharmaceutical product availability in the UK. The UK market is estimated at nearly £1 billion, and the deal aims to improve supply reliability and access. Both companies will explore further collaboration opportunities.TipranksTilray’s CC Pharma has entered into an agreement with Smartway PharmaceuticalsTilray Brands' pharmaceutical division announced that its European distribution subsidiary, CC Pharma, has entered into a strategic agreement with Smartway Pharmaceuticals to expand pharmaceutical product availability across the United Kingdom. The partnership is aimed at supporting continuity and expanding patient access to medicines within the UK healthcare system. Smartway CEO Josh Cocklin emphasized that the agreement will reduce supply interruptions and provide more predictable access to care for patients and healthcare practitioners.GlobeNewswireMarius Pharmaceuticals Partners with Smartway to Design and Manage the global Early Access Program for KYZATREX™ (testosterone undecanoate)Marius Pharmaceuticals and Smartway Pharmaceuticals announced a partnership to launch a global Early Access Program for KYZATREX (testosterone undecanoate) for hypogonadism. Smartway will be the exclusive Early Access Provider outside the USA, extending access to patients worldwide. The drug is licensed only in the USA and has demonstrated efficacy in a phase 3 study.